
New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country.
By KATIE THOMAS from NYT Health https://ift.tt/2toIJWM
via IFTTT
Drugs (Pharmaceuticals), Health Insurance and Managed Care
Source The New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét